Investigating the effects of aromatase inhibitors on the musculoskeletal system
Aromatase Inhibitors (AIs) are a standard of care for the adjuvant treatment of hormone responsive early carcinoma of the breast as demonstrated in a number of large international phase III randomised trials. Arthralgia was a somewhat unexpected side effect of this class of agents and has proven to...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Sheffield
2014
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.651256 |